Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05970341 · ClinicalTrials.gov registry record · NA
Kidney Health: Eat Well, Live Well
A NA study of Chronic Kidney Diseases, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 330
- Enrollment target
- 3
- Study locations
NCT05970341: Recruiting NA study of Chronic Kidney Diseases, sponsored by University of Texas at Austin.
NCT05970341 is a NA study of Chronic Kidney Diseases that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 330 participants, below the 440-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (25% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05970341, a NA study of Chronic Kidney Diseases, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
- 3
- Study locations
Study Summary
This two-arm, parallel randomized trial study will assess the efficacy of a 6-month (26 weeks) community-based program in reducing kidney injury (as Urine Albumin to Creatinine ratio, uACR), cardiovascular risk (as Hemoglobin A1C and blood pressure), mental health (as PHQ-8) and diet quality (as fruits and vegetables intake and Healthy Eating Index) in community-dwelling, low-income adults diagnosed with early chronic kidney disease (stages 2 or 3 and not on kidney replacement therapies) compared to educational materials and usual care alone.
Primary Outcome
Marker of kidney damage and a useful predictor of cardiovascular (CV) events in adults. Uses spot urine to estimate 24-hour urine albumin excretion. UACR \> 30 mg/g indicates kidney damage.
Conditions Studied
Interventions
- BEHAVIORAL 1. Welcome package
- BEHAVIORAL 2. Welcome information (phone or text)
- BEHAVIORAL 3. Produce delivery + Recipes customized to produce
- BEHAVIORAL 4. E-gift cards to a grocery store of choice
- BEHAVIORAL 5. Personalized practical & emotional support through a dedicated health partner
Study Locations (3)
Texas
- Harris Health System's Outpatient Center - Houston
- Harris Health System's Martin Luther King Jr. Health Center - Houston
- Harris Health System's Smith Clinic - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2023-12-06 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT05970341 shows while recruiting
NCT05970341 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 5 interventions - of which 1. Welcome package is the first listed.
NCT05970341 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05970341 about?
NCT05970341 is a clinical study titled "Kidney Health: Eat Well, Live Well". This two-arm, parallel randomized trial study will assess the efficacy of a 6-month (26 weeks) community-based program in reducing kidney injury (as Urine Albumin to Creatinine ratio, uACR), cardiovascular risk (as Hemoglobin A1C and blood pressure), mental health (as PHQ-8) and diet quality (as fru...
What is the current status of trial NCT05970341?
This trial is currently recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2023-12-06. Estimated completion is 2026-05.
What conditions does trial NCT05970341 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases.
What interventions are being tested in trial NCT05970341?
The interventions under investigation include: 1. Welcome package (BEHAVIORAL), 2. Welcome information (phone or text) (BEHAVIORAL), 3. Produce delivery + Recipes customized to produce (BEHAVIORAL), 4. E-gift cards to a grocery store of choice (BEHAVIORAL), 5. Personalized practical & emotional support through a dedicated health partner (BEHAVIORAL).
Who is sponsoring clinical trial NCT05970341?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05970341 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05970341's enrollment target sits among peer trials
330 20th of 73 higher than 53 of 73 other Chronic Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
-
Handgrip Exercise Training and CKD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI